Pfizer Lyrica Citizen Petition Against Generics Argues Drug Impurities Should Have Ceiling, Not Floor
This article was originally published in The Pink Sheet Daily
Executive Summary
Lupin, Actavis and Wockhardt’s novel attempt to establish a “not less than” level for an impurity in their generic pregabalin as a tactic in patent litigation should be rejected, Pfizer argues.